Good intentions. That's industry's verdict on the Canadian government's ambitious plans for more technological innovation to aid its beleaguered healthcare system. Actual entry of innovative products into the system? Well, that's another matter. At a meeting with government agencies in June, eighteen small Canadian-based companies complained that public procurement is focused too much on cost minimization at the expense of innovation and its value to patient care.